Convergence Investment Partners’s Sanofi SNY Stock Holding History

Convergence Investment Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-541	Closed	-$22K	–	808
2018 Q1	$22K	Buy	+541	New	+$22.5K	﹤0.01%	573
2015 Q2	–	Sell	-5,275	Closed	-$261K	–	411
2015 Q1	$261K	Buy	5,275 +660	+14%	+$31.6K	0.04%	334
2014 Q4	$210K	Sell	4,615 -1,547	-25%	-$75.1K	0.03%	334
2014 Q3	$348K	Buy	6,162 +861	+16%	+$46.2K	0.05%	313
2014 Q2	$282K	Sell	5,301 -2,597	-33%	-$138K	0.04%	324
2014 Q1	$413K	Sell	7,898 -2,191	-22%	-$111K	0.06%	284
2013 Q4	$541K	Sell	10,089 -1,893	-16%	-$97.7K	0.09%	256
2013 Q3	$607K	Sell	11,982 -3,258	-21%	-$166K	0.13%	192
2013 Q2	$785K	Buy	+15,240	New	+$812K	0.2%	151

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Convergence Investment Partners's SNY Position: Q2 2018 in Review

Convergence Investment Partners sold out of Sanofi (SNY) in Q2 2018, closing a stake of 541 shares — an estimated $22K sold.

Convergence Investment Partners first reported a position in SNY in Q2 2013 and held it in 9 quarters. The position peaked at $785K in Q2 2013. 478 funds tracked by Wall St. Rank hold SNY as of Q2 2018.

Convergence Investment Partners reported no remaining Sanofi position as of Q2 2018 after selling out during the quarter.
Convergence Investment Partners sold 541 Sanofi shares in Q2 2018, an estimated $22K.
Convergence Investment Partners first reported a position in Sanofi in Q2 2013 and held it in 9 quarters.
Convergence Investment Partners's Sanofi position peaked at $785K in Q2 2013.
478 funds tracked by Wall St. Rank held Sanofi as of Q2 2018.

Based on Convergence Investment Partners's 13F filing for Q2 2018, filed 7 Aug 2018.